Hasil Pencarian  ::  Simpan CSV :: Kembali

"Berbagai insiden risiko, seperti risiko kecurangan atau pelanggaran aturan, mendorong perusahaan meningkatkan penerapan Governance, Risk Management dan Compliance (GRC). Salah satu cara untuk meningkatkan penerapan GRC yaitu dengan mengintegrasikan ketiga komponen tersebut. PT.X juga perlu menerapkan integrasi ketiga komponen tersebut karena PT.X mengalami insiden risiko dimasa lalu, khususnya risiko pelanggaran kepatuhan. Sebelum implementasi GRC terintegrasi, Open and Compliance Ethics Group (OCEG) menyebutkan bahwa penting untuk mengevaluasi kesiapan perusahaan dalam menerapkan GRC. Penelitian ini bertujuan untuk mengevaluasi kesiapan PT.X dalam menerapkan GRC terintegrasi. Penelitian ini berbeda dengan penelitian terdahulu karena penelitian ini menggunakan model terbaru dari OCEG. Penelitian ini merupakan penelitian kualitatif dengan pendekatan studi kasus. Data diperoleh dari hasil review dokumen, survey serta hasil wawancara dengan ahli GRC, Senior Executive Vice President (SEVP) Business Support PT.X, dan manajer proyek PT.X. Hasil penelitian menunjukkan bahwa PT.X sudah siap untuk menerapkan GRC secara terintegrasi dengan komitmen yang kuat dari para top management serta terdapatnya beberapa hal yang sudah terintegrasi seperti penerapan manajemen risiko.

---

Various incident of risk such as fraud risk and compliance violation risk, forced companies to improve the implementation of governance, risk management, and compliance (GRC). One way to enhance the implementation of GRC is to integrate the three components. PT. X also needs to implement the integration of the three components because PT. X also has an incident of risk in the past, especially compliance violation risk. Before integrated GRC implementation, The Open and Compliance Ethics Group (OCEG) states that it is important to evaluate the company's readiness to implement an integrated GRC. Therefore, this research wants to evaluate the readiness of PT.X in implementing GRC. This research is different from previous studies because this research uses the latest model of Open and Compliance Ethics Group (OCEG). This research is a qualitative research with a case study approach. The data was collected by document review, survey and interviews with GRC experts, PT.X’s Senior Executive Vice President (SEVP) business support, and PT.X project manager. The result of this research shows that PT.X is ready to implement GRC in an integrated manner with a strong commitment from the top management. Several things have been integrated, such as the application of risk management"

"Pedagang Besar Farmasi (PBF) berperan sebagai distributor serta penghubung antara pemasok bahan baku ke industri farmasi, maupun industri farmasi ke fasilitas kesehatan. Dalam menjalankan tugasnya sebagai distributor obat dan/atau bahan obat, diperlukan standar untuk mengatur cara distribusi yang baik untuk memastikan terjaganya mutu selama proses distribusi. Salah satu hal penting dalam proses distribusi oleh PBF adalah penyimpanan yang memiliki ketentuan berbeda tergantung kategori atau jenis produknya. Pada penelitian ini, dilakukan evaluasi kesesuaian penyimpanan obat reguler, cold-chain product, psikotropika, dan prekursor farmasi di salah satu PBF terbesar di Indonesia, yaitu PT Anugerah Pharmindo Lestari (PT APL) – Jakarta Distribution Center (JDC) terhadap CDOB 2020. Pengumpulan data dilakukan melalui pengamatan di lapangan (observasi) dan melalui kegiatan tanya-jawab dengan narasumber (wawancara). Berdasarkan hasil evaluasi kesesuaian menggunakan metode evaluasi deskriptif dan analisis campuran dengan skala Guttman, PT APL-JDC telah memenuhi 90,91% (10 dari total 11 poin) ketentuan penyimpanan obat reguler menurut CDOB 2020, 83,33% (5 dari total 6 poin) ketentuan penyimpanan cold-chain product menurut CDOB 2020, serta 100% (3 dari total 3 poin) ketentuan penyimpanan psikotropika dan prekursor farmasi menurut CDOB 2020.

---

Pharmaceutical Wholesalers (PBF) act as distributors and intermediaries between suppliers of raw materials to the pharmaceutical industry, as well as the pharmaceutical industry to healthcare facilities. In carrying out its role as a distributor of drugs and pharmaceutical materials, PBF requires a standard to regulate suitable distribution methods to ensure quality is maintained during the distribution process. One of the crucial things in the distribution process by PBF is storage which has different provisions depending on the category or type of product. This study evaluated the suitability of regular drug storage, cold-chain products, psychotropics, and pharmaceutical precursors at one of the largest PBFs in Indonesia, namely PT Anugerah Pharmindo Lestari (PT APL) – Jakarta Distribution Center (JDC) for CDOB 2020. Data was collected through field observations and question-and-answer activities with informants (interviews). Based on the results of the conformity evaluation using the descriptive evaluation method and mixed analysis with the Guttman scale, PT APL-JDC has complied with 90.91% (10 out of a total of 11 points) of the regular drug storage requirements according to CDOB 2020, 83.33% (5 out of a total of 6 points) provisions for storage of cold-chain products according to CDOB 2020, and 100% (3 out of a total of 3 points) provisions for storage of psychotropics and pharmaceutical precursors according to CDOB 2020."